Kbc Group Nv Royalty Pharma PLC Transaction History

Kbc Group Nv

$36.3 Billion
Q4 2024

A detailed history of Kbc Group Nv transactions in Royalty Pharma PLC stock. As of the latest transaction made, Kbc Group Nv holds 41,554 shares of RPRX stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,554

Previous 41,554 -0.0%

Holding current value

$1.27 Million

Previous $1.18 Million 9.86%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$25.63 - $29.27 $412,156 - $470,690	16,081 Added 63.13%	41,554 $1.18 Million
Q1 2024 May 08, 2024	SELL	$27.46 - $31.33 $125,025 - $142,645	-4,553 Reduced 15.16%	25,473 $773,000
Q4 2023 Feb 13, 2024	SELL	$26.21 - $29.22 $1.56 Million - $1.74 Million	-59,430 Reduced 66.43%	30,026 $844,000
Q3 2023 Feb 15, 2024	SELL	$26.26 - $31.38 $1.57 Million - $1.88 Million	-59,800 Reduced 66.85%	29,656 $804,000
Q2 2023 Feb 15, 2024	BUY	$29.6 - $36.56 $1.71 Million - $2.11 Million	57,759 Added 182.22%	89,456 $2.75 Million
Q2 2023 Jul 28, 2023	SELL	$29.6 - $36.56 $186,864 - $230,803	-6,313 Reduced 6.59%	89,456 $2.75 Million
Q1 2023 Feb 14, 2024	BUY	$32.77 - $39.4 $2.1 Million - $2.52 Million	64,048 Added 201.91%	95,769 $3.45 Million
Q1 2023 May 04, 2023	BUY	$32.77 - $39.4 $2.1 Million - $2.52 Million	64,072 Added 202.14%	95,769 $3.45 Million
Q4 2022 Feb 14, 2024	BUY	$39.17 - $44.04 $11,555 - $12,991	295 Added 0.94%	31,721 $1.25 Million
Q3 2022 Feb 15, 2024	BUY	$39.88 - $44.65 $66,639 - $74,610	1,671 Added 5.57%	31,697 $1.27 Million
Q3 2022 Nov 08, 2022	BUY	$39.88 - $44.65 $36,450 - $40,810	914 Added 2.97%	31,697 $1.27 Million
Q2 2022 Feb 14, 2024	SELL	$37.53 - $44.22 $554,167 - $652,952	-14,766 Reduced 31.97%	31,426 $1.32 Million
Q2 2022 Jul 26, 2022	SELL	$37.53 - $44.22 $578,299 - $681,385	-15,409 Reduced 33.36%	30,783 $1.29 Million
Q1 2022 Feb 14, 2024	BUY	$37.46 - $42.44 $555,943 - $629,852	14,841 Added 47.34%	46,192 $1.8 Million
Q1 2022 May 06, 2022	BUY	$37.46 - $42.44 $555,943 - $629,852	14,841 Added 47.34%	46,192 $1.8 Million
Q4 2021 Feb 14, 2024	BUY	$35.17 - $42.48 $46,600 - $56,285	1,325 Added 4.41%	31,351 $1.25 Million
Q4 2021 Feb 03, 2022	BUY	$35.17 - $42.48 $87,678 - $105,902	2,493 Added 8.64%	31,351 $1.25 Million
Q3 2021 Nov 10, 2021	SELL	$36.14 - $42.24 $45,933 - $53,687	-1,271 Reduced 4.22%	28,858 $1.04 Million
Q2 2021 Aug 11, 2021	SELL	$39.85 - $46.63 $58,699 - $68,685	-1,473 Reduced 4.66%	30,129 $1.24 Million
Q1 2021 Apr 26, 2021	SELL	$42.34 - $52.82 $2.19 Million - $2.74 Million	-51,781 Reduced 62.1%	31,602 $1.38 Million
Q4 2020 Feb 10, 2021	BUY	$36.12 - $50.05 $3.01 Million - $4.17 Million	83,383 New	83,383 $4.17 Million

Others Institutions Holding RPRX

# of Institutions

410

Shares Held

284M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $13.4B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account